Common resistance features include enhanced DDR capacity, upregulation of anti-apoptotic signaling (e.g., overexpression of Bcl-2 family proteins), maintenance of cancer stem cell phenotypes, and increased activity of drug efflux pumps (Safa, 2020). Here, BCL2 is linked to cancer.